EXIQON Diagnostics has announced the beta test launch of a communication tool, PortiQo Doctor Portal which will electronically connect clients to Exiqon.
07/07/2009
STELLAR Pharmaceuticals has announced the launch of Neovisc Single Dose in the Canadian market.
08/07/2009
PERKINELMER has announced it has entered into a contract with ID Biological Systems to become its exclusive worldwide distributer for specimen collection cards used by newborn screening programs worldwide.
29/04/2009
THE NATURAL Orifice Surgery Consortium for Assessment and Research (NOSCAR) has announced Olympus' continuing commitment to funding research in an emerging minimally invasive transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery.
24/07/2009
The American Society for Microbiology (ASM) has published interim guidelines to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1.
30/10/2009
Schott Pharmaceutical Packaging has developed a new syringe system, the Schott InJentle, for the special needs of highly sensitive drugs. Its unique design offers improved drug stability and a gentle application.
17/12/2009
NITINOl Devices & Components has announced its acquisition of novel medical device anchoring technology from Phase One Medical, brokered by Hatch Medical.
04/03/2009
ACCORDING to a study found in the 18 March 2009 issue of the Journal of the American Medical Association, narcolepsy drug modafinil may be addictive.
20/03/2009
WELCH Allyn and its distributor Samden Technologies have assisted the Kingdom of Bhutan’s Ministry of Health to implement the Rural Telemedicine Project, which aims to provide lifesaving treatment to patients living in remote areas through digital transmission of data between basic health care centres and the country’s hospitals.
26/06/2009
Two patients have been surgically implanted with ImThera Medical's aura6000 neurostimulation device for treating tongue-based Obstructive Sleep Apnea (OSA). Patients are being enrolled in ImThera's pilot clinical investigation in Belgium with the first results expected to be published in the first half of 2010.
11/12/2009
US physicians will soon begin implanting a new medical device to improve breathing in patients with upper spinal-cord injuries or conditions that keep them from breathing independently.
30/11/2009
Medtronic has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. The company was recognised for its development and introduction of Deep Brain Stimulation (DBS) Therapy, which helps treat neurological conditions by delivering controlled electrical pulses to a specific part of the brain.
05/03/2010
GB Research predicts the market for aesthetic devices will regain positive growth to 2016.
16/02/2010